Cas:38875-74-0 4-Chloro-2-methylpyrimidine-5-carbonitrile manufacturer & supplier

Chemical Name:4-Chloro-2-methylpyrimidine-5-carbonitrile

CAS.NO:38875-74-0

Synonyms:4-Chloro-2-methylpyrimidine-5-carbonitrile;4-Chloro-2-methyl-5-pyrimidinecarbonitrile;5-Pyrimidinecarbonitrile, 4-chloro-2-methyl-

Molecular Formula:C₆H₄ClN₃

Molecular Weight:153.569

HS Code:2933599090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:272.8±20.0 °C at 760 mmHg

Density:1.4±0.1 g/cm3

Index of Refraction:1.556

PSA:49.57000

Exact Mass:153.009369

LogP:0.76

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-Chloro-2-methylpyrimidine-5-carbonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-Pyrimidinecarbonitrile, 4-chloro-2-methyl- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Chloro-2-methyl-5-pyrimidinecarbonitrile Use and application,4-Chloro-2-methylpyrimidine-5-carbonitrile technical grade,usp/ep/jp grade.

Related News: Johnson & Johnson’s Darzalex has comfortably been the only CD38 multiple myeloma drug on the market for years until Sanofi hit the scene last year with Sarclisa. Now, just as the competition’s slated to intensify, the U.S. company is building its case with new patient survival data. 4-Chloro-2-methylpyrimidine-5-carbonitrile manufacturer The United States has suspended imports of dogs from more than 100 countries where there’s a high rabies risk. 4-Chloro-2-methylpyrimidine-5-carbonitrile supplier Johnson & Johnson’s Darzalex has comfortably been the only CD38 multiple myeloma drug on the market for years until Sanofi hit the scene last year with Sarclisa. Now, just as the competition’s slated to intensify, the U.S. company is building its case with new patient survival data. 4-Chloro-2-methylpyrimidine-5-carbonitrile vendor The United States has suspended imports of dogs from more than 100 countries where there’s a high rabies risk. 4-Chloro-2-methylpyrimidine-5-carbonitrile factory What’s more, also at the EHA meeting, BeiGene’s Brukinsa showed it could outperform Imbruvica at triggering tumor responses while causing fewer cases of atrial fibrillation, a potentially dangerous heart side effect, in its own head-to-head phase 3 study in previously treated CLL.